Biocon Limited has informed the Exchange regarding a press release dated December 22, 2023, titled "Biocon Biologics Partners with Sandoz for the Distribution of Adalimumab BS Subcutaneous Injection [FKB]" in Japan".
Biocon Limited has informed the Exchange regarding a press release dated December 22, 2023, titled "Biocon Biologics Partners with Sandoz for the Distribution of Adalimumab BS Subcutaneous Injection [FKB]" in Japan".